| ossification | GO:0001503 | 216 | 0.993 | |
| cellular phosphate ion homeostasis | GO:0030643 | 2 | 0.992 | |
| cell maturation | GO:0048469 | 127 | 0.869 | |
| cation homeostasis | GO:0055080 | 212 | 0.850 | |
| stem cell development | GO:0048864 | 219 | 0.829 | |
| skeletal system development | GO:0001501 | 356 | 0.812 | |
| divalent inorganic anion homeostasis | GO:0072505 | 5 | 0.805 | |
| glial cell differentiation | GO:0010001 | 131 | 0.775 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.767 | |
| stem cell maintenance | GO:0019827 | 130 | 0.759 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.759 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.724 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.711 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.710 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.688 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.674 | |
| hormone secretion | GO:0046879 | 128 | 0.663 | |
| regulation of secretion | GO:0051046 | 274 | 0.662 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.630 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.599 | |
| aldosterone biosynthetic process | GO:0032342 | 1 | 0.585 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.581 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.581 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.571 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.570 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.568 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.563 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.558 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.542 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.540 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.537 | |
| fat cell differentiation | GO:0045444 | 160 | 0.536 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.533 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.530 | |
| anion transport | GO:0006820 | 177 | 0.526 | |
| cellular homeostasis | GO:0019725 | 240 | 0.515 | |
| cellular divalent inorganic anion homeostasis | GO:0072501 | 3 | 0.513 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.511 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.506 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.499 | |
| bone remodeling | GO:0046849 | 53 | 0.477 | |
| aldosterone metabolic process | GO:0032341 | 2 | 0.472 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.471 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.463 | |
| response to acid chemical | GO:0001101 | 111 | 0.453 | |
| connective tissue development | GO:0061448 | 179 | 0.448 | |
| response to growth factor | GO:0070848 | 198 | 0.426 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.424 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.413 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.408 | |
| gliogenesis | GO:0042063 | 141 | 0.405 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.397 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.391 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.386 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.378 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.375 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.370 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.368 | |
| cartilage development | GO:0051216 | 140 | 0.366 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.357 | |
| forebrain development | GO:0030900 | 302 | 0.353 | |
| limb morphogenesis | GO:0035108 | 149 | 0.353 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.346 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.343 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.343 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.341 | |
| kidney development | GO:0001822 | 213 | 0.336 | |
| phosphate ion transmembrane transport | GO:0035435 | 2 | 0.336 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.333 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.330 | |
| negative regulation of steroid metabolic process | GO:0045939 | 8 | 0.327 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.326 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.322 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.311 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.310 | |
| epithelial cell development | GO:0002064 | 159 | 0.306 | |
| mesenchymal cell differentiation involved in lung development | GO:0060915 | 2 | 0.294 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.290 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.289 | |
| neuronal stem cell division | GO:0036445 | 10 | 0.288 | |
| phosphate ion homeostasis | GO:0055062 | 5 | 0.286 | |
| response to inorganic substance | GO:0010035 | 96 | 0.284 | |
| appendage development | GO:0048736 | 166 | 0.283 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.280 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.270 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.264 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.264 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.261 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.260 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.259 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.257 | |
| regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072039 | 4 | 0.252 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.249 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.248 | |
| sensory perception | GO:0007600 | 245 | 0.247 | Mouse |
| muscle tissue development | GO:0060537 | 308 | 0.245 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.244 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.244 | |
| membrane organization | GO:0061024 | 245 | 0.244 | |
| developmental maturation | GO:0021700 | 193 | 0.237 | |
| brain derived neurotrophic factor receptor signaling pathway | GO:0031547 | 3 | 0.235 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.235 | |
| jnk cascade | GO:0007254 | 72 | 0.234 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.233 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.231 | |
| circulatory system process | GO:0003013 | 197 | 0.230 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.230 | |
| angiogenesis | GO:0001525 | 201 | 0.229 | |
| bone development | GO:0060348 | 120 | 0.228 | |
| sodium ion transport | GO:0006814 | 73 | 0.228 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.223 | |
| negative regulation of growth | GO:0045926 | 99 | 0.222 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.221 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.221 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.217 | |
| lung epithelium development | GO:0060428 | 37 | 0.217 | |
| osteoblast development | GO:0002076 | 17 | 0.216 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.214 | |
| axial mesodermal cell fate commitment | GO:0048322 | 1 | 0.214 | |
| response to amino acid | GO:0043200 | 37 | 0.213 | |
| cellular trivalent inorganic anion homeostasis | GO:0072502 | 2 | 0.213 | |
| positive regulation of growth | GO:0045927 | 104 | 0.209 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.209 | |
| transmembrane transport | GO:0055085 | 412 | 0.208 | |
| blood circulation | GO:0008015 | 195 | 0.208 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.206 | |
| diencephalon development | GO:0021536 | 63 | 0.205 | |
| mammary placode formation | GO:0060596 | 4 | 0.204 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.203 | |
| defense response to other organism | GO:0098542 | 197 | 0.202 | |
| neuron projection guidance | GO:0097485 | 141 | 0.201 | |
| enamel mineralization | GO:0070166 | 7 | 0.200 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.199 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.197 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.190 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.190 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.190 | |
| synaptic transmission | GO:0007268 | 329 | 0.189 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.188 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.187 | |
| bone morphogenesis | GO:0060349 | 78 | 0.186 | |
| tooth mineralization | GO:0034505 | 9 | 0.185 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.181 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.178 | |
| renal system development | GO:0072001 | 225 | 0.177 | |
| sensory perception of sound | GO:0007605 | 97 | 0.174 | |
| regulation of positive chemotaxis | GO:0050926 | 7 | 0.173 | |
| neuroblast division | GO:0055057 | 10 | 0.172 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.171 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.171 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.170 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.170 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.170 | |
| face development | GO:0060324 | 38 | 0.168 | |
| embryonic genitalia morphogenesis | GO:0030538 | 4 | 0.167 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.166 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.166 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.164 | |
| response to nutrient levels | GO:0031667 | 109 | 0.162 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.162 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.162 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.160 | |
| mapk cascade | GO:0000165 | 281 | 0.160 | |
| establishment or maintenance of neuroblast polarity | GO:0045196 | 1 | 0.160 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.159 | |
| pallium development | GO:0021543 | 120 | 0.157 | |
| regulation of ossification | GO:0030278 | 112 | 0.157 | |
| regulation of aldosterone metabolic process | GO:0032344 | 1 | 0.156 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.155 | |
| telencephalon development | GO:0021537 | 186 | 0.155 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.155 | |
| placenta development | GO:0001890 | 140 | 0.154 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.153 | |
| forebrain ventricular zone progenitor cell division | GO:0021869 | 6 | 0.152 | |
| tissue remodeling | GO:0048771 | 102 | 0.152 | |
| camera type eye development | GO:0043010 | 266 | 0.151 | |
| synapse assembly | GO:0007416 | 56 | 0.151 | |
| regulation of heart growth | GO:0060420 | 31 | 0.150 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.149 | |
| ventricular zone neuroblast division | GO:0021847 | 3 | 0.148 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.147 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.146 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.146 | |
| peptide transport | GO:0015833 | 133 | 0.145 | |
| organic anion transport | GO:0015711 | 137 | 0.144 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.144 | |
| blastocyst formation | GO:0001825 | 33 | 0.144 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.143 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.141 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.141 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.140 | |
| prenylation | GO:0097354 | 3 | 0.139 | |
| extracellular matrix cell signaling | GO:0035426 | 5 | 0.139 | |
| establishment of neuroblast polarity | GO:0045200 | 1 | 0.139 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.139 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.139 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.139 | |
| response to retinoic acid | GO:0032526 | 56 | 0.139 | |
| embryonic skeletal joint development | GO:0072498 | 13 | 0.137 | |
| kidney epithelium development | GO:0072073 | 121 | 0.137 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.136 | |
| cytokine production | GO:0001816 | 319 | 0.136 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.135 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.133 | |
| mesenchyme development | GO:0060485 | 152 | 0.133 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.133 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.131 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.130 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.130 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.130 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.129 | |
| metanephric mesenchymal cell proliferation involved in metanephros development | GO:0072136 | 2 | 0.129 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.129 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.129 | |
| digestive tract development | GO:0048565 | 190 | 0.129 | |
| neuronal action potential | GO:0019228 | 54 | 0.128 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.128 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.128 | |
| regulation of protein geranylgeranylation | GO:2000539 | 2 | 0.128 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.127 | |
| bone resorption | GO:0045453 | 38 | 0.127 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.127 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.126 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.126 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.126 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.125 | |
| protein catabolic process | GO:0030163 | 221 | 0.124 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.123 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.122 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.121 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.121 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.121 | |
| morphogenesis of an epithelial bud | GO:0060572 | 18 | 0.120 | |
| renal vesicle induction | GO:0072034 | 3 | 0.120 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.119 | |
| mammary gland bud formation | GO:0060615 | 2 | 0.119 | |
| endocytosis | GO:0006897 | 168 | 0.118 | |
| cation transport | GO:0006812 | 399 | 0.118 | |
| negative regulation of stem cell maintenance | GO:1902455 | 4 | 0.118 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.118 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.118 | |
| glial cell development | GO:0021782 | 54 | 0.117 | |
| ear morphogenesis | GO:0042471 | 118 | 0.117 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.117 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.115 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.115 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.114 | |
| striated muscle cell development | GO:0055002 | 125 | 0.113 | |
| keratinocyte migration | GO:0051546 | 3 | 0.111 | |
| immune effector process | GO:0002252 | 321 | 0.111 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.110 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.110 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.110 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.110 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.109 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.109 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.108 | |
| epithelial cell migration | GO:0010631 | 63 | 0.107 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.107 | |
| response to vitamin d | GO:0033280 | 3 | 0.107 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.106 | |
| forebrain cell migration | GO:0021885 | 58 | 0.106 | |
| regulation of protein transport | GO:0051223 | 163 | 0.106 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.105 | |
| positive regulation of neuron projection regeneration | GO:0070572 | 2 | 0.104 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.103 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.103 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.101 | |
| regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000163 | 1 | 0.101 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.101 | |
| locomotory behavior | GO:0007626 | 195 | 0.100 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 29 | 0.100 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.100 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.099 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.098 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.098 | |
| positive regulation of tendon cell differentiation | GO:2001051 | 1 | 0.098 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.098 | |
| tissue homeostasis | GO:0001894 | 115 | 0.098 | |
| trachea formation | GO:0060440 | 3 | 0.097 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.096 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.096 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.095 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.095 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.095 | |
| axonogenesis | GO:0007409 | 274 | 0.095 | |
| regulation of astrocyte differentiation | GO:0048710 | 20 | 0.095 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.095 | |
| insulin secretion | GO:0030073 | 89 | 0.094 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.094 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.094 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.094 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.094 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.094 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.093 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.093 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.092 | |
| endoderm development | GO:0007492 | 45 | 0.092 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.092 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.092 | |
| gland development | GO:0048732 | 330 | 0.091 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.091 | |
| response to ischemia | GO:0002931 | 14 | 0.091 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.091 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.090 | |
| c21 steroid hormone metabolic process | GO:0008207 | 7 | 0.090 | |
| oligodendrocyte development | GO:0014003 | 20 | 0.090 | |
| regulation of protein localization | GO:0032880 | 231 | 0.089 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.089 | |
| prostate gland morphogenetic growth | GO:0060737 | 4 | 0.088 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.088 | |
| regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry | GO:1900094 | 2 | 0.088 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.087 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.087 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.087 | |
| protein geranylgeranylation | GO:0018344 | 3 | 0.086 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.086 | |
| wound healing | GO:0042060 | 157 | 0.086 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.086 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.086 | |
| roof plate formation | GO:0021509 | 1 | 0.085 | |
| limb development | GO:0060173 | 166 | 0.085 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.085 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.085 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.085 | |
| regulation of rac gtpase activity | GO:0032314 | 13 | 0.085 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.084 | |
| monovalent inorganic anion homeostasis | GO:0055083 | 6 | 0.084 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.084 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.084 | |
| learning or memory | GO:0007611 | 148 | 0.084 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.083 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.083 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.083 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.083 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.083 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.082 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.082 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.082 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.082 | |
| positive regulation of bone mineralization | GO:0030501 | 12 | 0.082 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.082 | |
| specification of organ position | GO:0010159 | 3 | 0.082 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.082 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.082 | |
| regulation of neuron death | GO:1901214 | 134 | 0.081 | |
| metanephros development | GO:0001656 | 79 | 0.080 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.080 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.080 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.080 | |
| protein targeting | GO:0006605 | 143 | 0.080 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.080 | |
| glucose homeostasis | GO:0042593 | 128 | 0.078 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.078 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.078 | |
| plasma membrane organization | GO:0007009 | 90 | 0.077 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.076 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.076 | |
| cell division | GO:0051301 | 120 | 0.075 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.075 | |
| molting cycle | GO:0042303 | 90 | 0.075 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.075 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.075 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.074 | |
| camp mediated signaling | GO:0019933 | 15 | 0.074 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.073 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.073 | |
| response to testosterone | GO:0033574 | 3 | 0.073 | |
| organ growth | GO:0035265 | 117 | 0.073 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.073 | |
| mesoderm development | GO:0007498 | 100 | 0.073 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.073 | |
| trophectodermal cellular morphogenesis | GO:0001831 | 3 | 0.072 | |
| regulation of system process | GO:0044057 | 200 | 0.072 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.072 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.072 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.072 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.072 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.071 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.071 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.071 | |
| cellular response to lipid | GO:0071396 | 145 | 0.071 | |
| metanephric nephron tubule development | GO:0072234 | 16 | 0.071 | |
| regulation of cell size | GO:0008361 | 72 | 0.071 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.070 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.070 | |
| b cell activation | GO:0042113 | 161 | 0.070 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.070 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.070 | |
| heart morphogenesis | GO:0003007 | 178 | 0.070 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.070 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.070 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.070 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.070 | |
| adaptive immune response | GO:0002250 | 155 | 0.069 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.069 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.068 | |
| calcium ion transport | GO:0006816 | 159 | 0.068 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.068 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.068 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.068 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.067 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.067 | |
| organic acid transport | GO:0015849 | 101 | 0.067 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.067 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.067 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.067 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.067 | |
| biomineral tissue development | GO:0031214 | 64 | 0.066 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.066 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.066 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.066 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.066 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.065 | |
| axon guidance | GO:0007411 | 141 | 0.065 | |
| chondrocyte development | GO:0002063 | 24 | 0.065 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.065 | |
| response to oxygen levels | GO:0070482 | 62 | 0.065 | |
| regulation of timing of cell differentiation | GO:0048505 | 11 | 0.065 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.064 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.064 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.064 | |
| glucose transport | GO:0015758 | 56 | 0.064 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.064 | Mouse |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.063 | |
| positive chemotaxis | GO:0050918 | 18 | 0.063 | |
| regulation of cell motility | GO:2000145 | 236 | 0.063 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.063 | |
| protein localization to organelle | GO:0033365 | 185 | 0.063 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.063 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.062 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.062 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.062 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.062 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.062 | |
| oocyte differentiation | GO:0009994 | 35 | 0.061 | |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 15 | 0.061 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.061 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.061 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.061 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.061 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.061 | |
| kidney mesenchyme morphogenesis | GO:0072131 | 4 | 0.060 | |
| membrane invagination | GO:0010324 | 17 | 0.060 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.060 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.059 | |
| response to monosaccharide | GO:0034284 | 67 | 0.059 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.059 | |
| axon ensheathment | GO:0008366 | 76 | 0.059 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.059 | |
| cardiac cell development | GO:0055006 | 41 | 0.058 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.058 | |
| cognition | GO:0050890 | 149 | 0.057 | |
| negative regulation of muscle hypertrophy | GO:0014741 | 9 | 0.057 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.057 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.057 | |
| positive regulation of heart growth | GO:0060421 | 18 | 0.057 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.056 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.056 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.056 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.055 | |
| branch elongation involved in salivary gland morphogenesis | GO:0060667 | 2 | 0.055 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.055 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.055 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.055 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.055 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.054 | |
| peptide secretion | GO:0002790 | 114 | 0.054 | |
| regulation of mesenchymal cell apoptotic process | GO:2001053 | 14 | 0.054 | |
| tissue migration | GO:0090130 | 68 | 0.054 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.054 | |
| sterol transport | GO:0015918 | 38 | 0.054 | |
| germ cell development | GO:0007281 | 185 | 0.053 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.053 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.053 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.053 | |
| embryonic skeletal joint morphogenesis | GO:0060272 | 11 | 0.053 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.053 | |
| toxin transport | GO:1901998 | 38 | 0.053 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.053 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.052 | |
| positive regulation of mesenchymal cell proliferation involved in ureter development | GO:2000729 | 3 | 0.052 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.052 | |
| replacement ossification | GO:0036075 | 26 | 0.052 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.052 | |
| insulin like growth factor receptor signaling pathway | GO:0048009 | 21 | 0.052 | |
